Allergan to buy dry eye disease-treatment maker Oculeve for $125 million
July 06, 2015 at 07:47 AM EDT
Botox maker Allergan PLC agrees to buy dry-eye disease treatment maker Oculeve for $125 million in cash.
Allergan to buy dry eye disease-treatment maker Oculeve for $125 million
By:
MarketWatch
July 06, 2015 at 07:47 AM EDT
Botox maker Allergan PLC agrees to buy dry-eye disease treatment maker Oculeve for $125 million in cash.
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|